Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Natalia Kuzubova (Saint-Petersburg, Russian Federation), Nataliya Kuzubova, Elena Lebedeva, Anatoliy Fedin, Tatiana Preobrazhenskaya. Effect of drugs with pleiotropic properties on tone of pulmonary arteries and bronchi in obstructive lung pathology model. Eur Respir J 2015; 46: Suppl. 59, 2445

Member's Comments

No comment yet.

Related content which might interest you: Dilatation reserve of pulmonary arteries at stages of COPD experimental model Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans Source: Eur Respir J 2005; 25: 173-180 Year: 2005 Pulmonary hypertension: future therapies Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=84 Year: 2004 Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease> Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Pulmonary hypertension in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 892-905 Year: 2003 Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Source: Eur Respir J 2002; 20: 332-338 Year: 2002 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Reducing cholinergic constriction: the major reversible mechanism in COPD Source: Eur Respir Rev 2006; 15: 32-36 Year: 2006 Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model Source: Annual Congress 2006 - Airway epithelial cells in inflammation Year: 2006 Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls Source: International Congress 2016 – Systemic biomarkers Year: 2016 Patterns of cardiopulmonary response to exercise in lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69 Year: 2007 The effect of nutrition on the pulmonary functions in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Pharmacological actions of statins: potential utility in COPD Source: Eur Respir Rev 2009; 18: 222-232 Year: 2009 Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Novel compounds for WNT/ß-catenin induced lung repair in chronic obstructive pulmonary disease Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Mechanisms underlying pulmonary vascular changes in COPD patients Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016